Global Nucleic Acids for Molecular Diagnosis Market Growth (Status and Outlook) 2024-2030

Global Nucleic Acids for Molecular Diagnosis Market Growth (Status and Outlook) 2024-2030

Nucleic acids for molecular diagnosis refer to the use of DNA or RNA molecules to detect, identify, or quantify specific genetic sequences associated with diseases, pathogens, or other biological conditions. Molecular diagnosis using nucleic acids is a cornerstone of modern diagnostics, offering highly sensitive and specific methods for identifying genetic mutations, infectious agents, and other molecular markers.

The global Nucleic Acids for Molecular Diagnosis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Nucleic Acids for Molecular Diagnosis Industry Forecast” looks at past sales and reviews total world Nucleic Acids for Molecular Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acids for Molecular Diagnosis sales for 2023 through 2029. With Nucleic Acids for Molecular Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acids for Molecular Diagnosis industry.

This Insight Report provides a comprehensive analysis of the global Nucleic Acids for Molecular Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acids for Molecular Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acids for Molecular Diagnosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acids for Molecular Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acids for Molecular Diagnosis.

United States market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Nucleic Acids for Molecular Diagnosis players cover Danaher Corporation, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acids for Molecular Diagnosis market by product type, application, key players and key regions and countries.

Segmentation by Type:
DNA Series
RNA Series

Segmentation by Application:
Infectious Diseases
Early Cancer Screening
Blood Screening
Genetic Diseases
Genome Sequencing
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
DNA Series
RNA Series

Segmentation by Application:
Infectious Diseases
Early Cancer Screening
Blood Screening
Genetic Diseases
Genome Sequencing
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Danaher Corporation
Merck KGaA
Eurofins Scientific SE
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Kaneka Eurogentec S.A.
Aji Bio-Pharma
L.G.C Biosearch Technologies
Integrated DNA Technologies
Bio-synthesis Inc.
metabion
QIAGEN
Hongene
Synthgene

Please note: The report will take approximately 2 business days to prepare and deliver.